Domenico Regoli

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Anatomy

Procedures

Electric Stimulation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Trapella Claudio; Fischetti Carmela; Pela' Michela; Lazzari Ilaria; Guerrini Remo; Calo' Girolamo; Rizzi Anna; Camarda Valeria; Lambert David G; McDonald John; Regoli Domenico; Salvadori Severo
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.
Guerrini Remo; Camarda Valeria; Trapella Claudio; Caló Girolamo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
Fischetti Carmela; Camarda Valeria; Rizzi Anna; Pelà Michela; Trapella Claudio; Guerrini Remo; McDonald John; Lambert David G; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Domenico Regoli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Trapella Claudio; Fischetti Carmela; Pela' Michela; Lazzari Ilaria; Guerrini Remo; Calo' Girolamo; Rizzi Anna; Camarda Valeria; Lambert David G; McDonald John; Regoli Domenico; Salvadori Severo
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.
Bioorganic & medicinal chemistry 2009;17(14):5080-95.
2009: Guerrini Remo; Camarda Valeria; Trapella Claudio; Caló Girolamo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
Journal of medicinal chemistry 2009;52(13):4068-71.
2009: Fischetti Carmela; Camarda Valeria; Rizzi Anna; Pelà Michela; Trapella Claudio; Guerrini Remo; McDonald John; Lambert David G; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.
European journal of pharmacology 2009;614(1-3):50-7.
2009: Batuwangala Madura; Camarda Valeria; McDonald John; Marzola Erika; Lambert David G; Ng Leong L; Calo' Girolamo; Regoli Domenico; Trapella Claudio; Guerrini Remo; Salvadori Severo
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor.
Peptides 2009;30(6):1130-6.
2009: Camarda Valeria; Fischetti Carmela; Anzellotti Nicholas; Molinari Paola; Ambrosio Caterina; Kostenis Evi; Regoli Domenico; Trapella Claudio; Guerrini Remo; Severo Salvadori; Calo Girolamo
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galphaqi5.
Naunyn-Schmiedeberg's archives of pharmacology 2009;379(6):599-607.
2009: Camarda Valeria; Rizzi Anna; Ruzza Chiara; Zucchini Silvia; Marzola Giuliano; Marzola Erika; Guerrini Remo; Salvadori Severo; Reinscheid Rainer K; Regoli Domenico; Calò Girolamo
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
The Journal of pharmacology and experimental therapeutics 2009;328(2):549-55.
2009: Guerrini Remo; Camarda Valeria; Trapella Claudio; Calò Girolamo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
Journal of medicinal chemistry 2009;52(2):524-9.
2008: Camarda Valeria; Trapella Claudio; Calo' Girolamo; Guerrini Remo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Structure-activity study at positions 3 and 4 of human neuropeptide S.
Bioorganic & medicinal chemistry 2008;16(19):8841-5.
2008: Rizzi A; Vergura R; Marzola G; Ruzza C; Guerrini R; Salvadori S; Regoli D; Calo G
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.
British journal of pharmacology 2008;154(2):471-9.
2008: Marzola Erika; Camarda Valeria; Batuwangala Madura; Lambert David G; Calo' Girolamo; Guerrini Remo; Trapella Claudio; Regoli Domenico; Tomatis Roberto; Salvadori Severo
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
Peptides 2008;29(5):674-9.
2008: Camarda Valeria; Trapella Claudio; Calo Girolamo; Guerrini Remo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
Journal of medicinal chemistry 2008;51(3):655-8.
2008: Vergura Raffaella; Balboni Gianfranco; Spagnolo Barbara; Gavioli Elaine; Lambert David G; McDonald John; Trapella Claudio; Lazarus Lawrence H; Regoli Domenico; Guerrini Remo; Salvadori Severo; Caló Girolamo
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.
Peptides 2008;29(1):93-103.
2007: Lungu C; Dias J P; França C Estevão de; Ongali B; Regoli D; Moldovan F; Couture R
Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.
Neuropeptides 2007;41(6):375-87.
2007: Tancredi Teodorico; Guerrini Remo; Marzola Erika; Trapella Claudio; Calo Girolamo; Regoli Domenico; Reinscheid Rainer K; Camarda Valeria; Salvadori Severo; Temussi Piero Andrea
Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.
Journal of medicinal chemistry 2007;50(18):4501-8.
2007: Arduin Marika; Spagnolo Barbara; Calò Girolamo; Guerrini Remo; Carrà Giacomo; Fischetti Carmela; Trapella Claudio; Marzola Erika; McDonald John; Lambert David G; Regoli Domenico; Salvadori Severo
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
Bioorganic & medicinal chemistry 2007;15(13):4434-43.
2007: Rizzi Anna; Spagnolo Barbara; Wainford Richard D; Fischetti Carmela; Guerrini Remo; Marzola Giuliano; Baldisserotto Anna; Salvadori Severo; Regoli Domenico; Kapusta Daniel R; Calo Girolamo
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Peptides 2007;28(6):1240-51.
2007: Gavioli Elaine C; Rizzi Anna; Marzola Giuliano; Zucchini Silvia; Regoli Domenico; Calo' Girolamo
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice.
Peptides 2007;28(6):1229-39.
2007: Spagnolo Barbara; Carrà Giacomo; Fantin Martina; Fischetti Carmela; Hebbes Chris; McDonald John; Barnes Timothy A; Rizzi Anna; Trapella Claudio; Fanton Giulia; Morari Michele; Lambert Dave G; Regoli Domenico; Calò Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):961-7.
2007: Rizzi Anna; Gavioli Elaine C; Marzola Giuliano; Spagnolo Barbara; Zucchini Silvia; Ciccocioppo Roberto; Trapella Claudio; Regoli Domenico; Calò Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):968-74.
2007: Nazzaro Cristiano; Rizzi Anna; Salvadori Severo; Guerrini Remo; Regoli Domenico; Zeilhofer Hanns Ulrich; Calo Girolamo
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
Peptides 2007;28(3):663-9.
2006: Vergura Raffaella; Valenti Elena; Hebbes Christopher P; Gavioli Elaine C; Spagnolo Barbara; McDonald John; Lambert David G; Balboni Gianfranco; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
Peptides 2006;27(12):3322-30.
2006: Lazzeri Massimo; Calò Girolamo; Spinelli Michele; Malaguti Silvia; Guerrini Remo; Salvadori Severo; Beneforti Patrizia; Regoli Domenico; Turini Damiano
Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study.
The Journal of urology 2006;176(5):2098-102.
2006: Rizzi Anna; Nazzaro Cristiano; Marzola G Giuliano; Zucchini Silvia; Trapella Claudio; Guerrini Remo; Zeilhofer Hanns Ulrich; Regoli Domenico; Calo' Girolamo
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
Pain 2006;124(1-2):100-8.
2006: Roth Adelheid L; Marzola Erika; Rizzi Anna; Arduin Marika; Trapella Claudio; Corti Corrado; Vergura Raffaella; Martinelli Prisca; Salvadori Severo; Regoli Domenico; Corsi Mauro; Cavanni Paolo; Caló Girolamo; Guerrini Remo
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
The Journal of biological chemistry 2006;281(30):20809-16.
2006: Trapella Claudio; Guerrini Remo; Piccagli Laura; Calo' Girolamo; Carra' Giacomo; Spagnolo Barbara; Rubini Samantha; Fanton Giulia; Hebbes Christopher; McDonald John; Lambert David G; Regoli Domenico; Salvadori Severo
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist.
Bioorganic & medicinal chemistry 2006;14(3):692-704.
2006: Camarda Valeria; Spagnol Martina; Song Wei; Vergura Raffaella; Roth Adelheid L; Thompson Jonathan P; Rowbotham David J; Guerrini Remo; Marzola Erika; Salvadori Severo; Cavanni Paolo; Regoli Domenico; Douglas Stephen A; Lambert David G; Calò Girolamo
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803).
British journal of pharmacology 2006;147(1):92-100.
2005: Carra' G; Calo' G; Spagnolo B; Guerrini R; Arduin M; Marzola E; Trapella C; Regoli D; Salvadori S
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.
The journal of peptide research : official journal of the American Peptide Society 2005;66(1):39-47.
2005: Guerrini Remo; Caló Girolamo; Lambert David G; Carrá Giacomo; Arduin Marika; Barnes Tim A; McDonald John; Rizzi Daniela; Trapella Claudio; Marzola Erika; Rowbotham David J; Regoli Domenico; Salvadori Severo
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Journal of medicinal chemistry 2005;48(5):1421-7.
2005: Tancredi Teodorico; Carrà Giacomo; Guerrini Remo; Arduin Marika; Calò Girolamo; Regoli Domenico; Salvadori Severo; Temussi Piero Andrea
The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ.
Chemistry (Weinheim an der Bergstrasse, Germany) 2005;11(7):2061-70.
2005: Carrà Giacomo; Rizzi Anna; Guerrini Remo; Barnes Timothy A; McDonald John; Hebbes Christopher P; Mela Flora; Kenigs Velga A; Marzola Giuliano; Rizzi Daniela; Gavioli Elaine; Zucchini Silvia; Regoli Domenico; Morari Michele; Salvadori Severo; Rowbotham David J; Lambert David G; Kapusta Daniel R; Calo' Girolamo
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1114-23.
2005: Guerrini Remo; Camarda Valeria; Marzola Erika; Arduin Marika; Calo Girolamo; Spagnol Martina; Rizzi Anna; Salvadori Severo; Regoli Domenico
Structure-activity relationship study on human urotensin II.
Journal of peptide science : an official publication of the European Peptide Society 2005;11(2):85-90.
2005: Calo Girolamo; Guerrini Remo; Rizzi Anna; Salvadori Severo; Burmeister Melissa; Kapusta Daniel R; Lambert David G; Regoli Domenico
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
CNS drug reviews 2005;11(2):97-112.
2004: Vergura Raffaella; Camarda Valeria; Rizzi Anna; Spagnol Martina; Guerrini Remo; Calo' Girolamo; Salvadori Severo; Regoli Domenico
Urotensin II stimulates plasma extravasation in mice via UT receptor activation.
Naunyn-Schmiedeberg's archives of pharmacology 2004;370(5):347-52.
2004: Camarda Valeria; Song Wei; Marzola Erika; Spagnol Martina; Guerrini Remo; Salvadori Severo; Regoli Domenico; Thompson Jonathan P; Rowbotham David J; Behm David J; Douglas Stephen A; Calo' Girolamo; Lambert David G
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
European journal of pharmacology 2004;498(1-3):83-6.
2004: Gavioli E C; Vaughan C W; Marzola G; Guerrini R; Mitchell V A; Zucchini S; De Lima T C M; Rae G A; Salvadori S; Regoli D; Calo' G
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
Naunyn-Schmiedeberg's archives of pharmacology 2004;369(6):547-53.
2004: Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
The journal of peptide research : official journal of the American Peptide Society 2004;63(6):477-84.
2003: Ongali Brice; Campos Maria Martha; Bregola Gianni; Rodi Donata; Regoli Domenico; Thibault Gaétan; Simonato Michele; Couture Réjean
Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy.
The Journal of comparative neurology 2003;461(4):506-19.
2003: Ongali Brice; Buck Hudson de Sousa; Cloutier Frank; Legault Francine; Regoli Domenico; Lambert Chantal; Thibault Gaétan; Couture Réjean
Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord.
American journal of physiology. Heart and circulatory physiology 2003;284(6):H1949-58.
2003: Gavioli E C; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima T C M; Rae G A; Salvadori S; Regoli D; Calo G
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.
The European journal of neuroscience 2003;17(9):1987-90.
2003: Lazzeri Massimo; Calò Girolamo; Spinelli Michele; Guerrini Remo; Salvadori Severo; Beneforti Patrizia; Sandri Sandro; Regoli Domenico; Turini Damiano
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
Urology 2003;61(5):946-50.
2003: Guerrini Remo; Rizzi Daniela; Zucchini Marina; Tomatis Roberto; Regoli Domenico; Calo' Girolamo; Salvadori Severo
Nociceptin/Orphanin FQ(1-13)NH2 analogues modified in the Phe1-Gly2 peptide bond.
Bioorganic & medicinal chemistry letters 2003;13(3):365-8.
2003: Vianna Rose Mari J; Ongali Brice; Regoli Domenico; Calixto João Batista; Couture Réjean
Up-regulation of kinin B1 receptor in the lung of streptozotocin-diabetic rat: autoradiographic and functional evidence.
British journal of pharmacology 2003;138(1):13-22.
2002: Rizzi Anna; Rizzi Daniela; Marzola Giuliano; Regoli Domenico; Larsen Bjarne Due; Petersen Jorgen Soberg; Calo' Girolamo
Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.
British journal of pharmacology 2002;137(3):369-74.
2002: Camarda Valeria; Guerrini Remo; Kostenis Evi; Rizzi Anna; Calò Girolamo; Hattenberger Almut; Zucchini Marina; Salvadori Severo; Regoli Domenico
A new ligand for the urotensin II receptor.
British journal of pharmacology 2002;137(3):311-4.
2002: Rizzi Anna; Salis Maria Bonaria; Ciccocioppo Roberto; Marzola Giuliano; Bigoni Raffaella; Guerrini Remo; Massi Maurizio; Madeddu Paolo; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(6):450-6.
2002: Bigoni Raffaella; Rizzi Daniela; Rizzi Anna; Camarda Valeria; Guerrini Remo; Lambert David G; Hashiba Eiji; Berger Hartmut; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(6):442-9.
2002: Camarda V; Rizzi A; Calo G; Guerrini R; Salvadori S; Regoli D
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.
Life sciences 2002;71(4):363-70.
2002: Bigoni R; Caò G; Rizzi A; Okawa H; Regoli D; Smart D; Lambert D G
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.
Canadian journal of physiology and pharmacology 2002;80(5):407-12.
2002: Calo Girolamo; Rizzi Anna; Rizzi Daniela; Bigoni Raffaella; Guerrini Remo; Marzola Giuliano; Marti Matteo; McDonald John; Morari Michele; Lambert David G; Salvadori Severo; Regoli Domenico
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
British journal of pharmacology 2002;136(2):303-11.
2002: Camarda V; Rizzi A; Calo G; Wirth K; Regoli D
Pharmacological characterisation of novel kinin B2 receptor ligands.
Canadian journal of physiology and pharmacology 2002;80(4):281-6.
2002: Calo' Girolamo; Rizzi Anna; Bigoni Raffaella; Guerrini Remo; Salvadori Severo; Regoli Domenico
Pharmacological profile of nociceptin/orphanin FQ receptors.
Clinical and experimental pharmacology & physiology 2002;29(3):223-8.
2002: Camarda Valeria; Rizzi Anna; Calò Girolamo; Gendron Gabrielle; Perron Stephan I; Kostenis Evi; Zamboni Paolo; Mascoli Francesco; Regoli Domenico
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(2):141-9.
2002: Rizzi Daniela; Rizzi Anna; Bigoni Raffaella; Camarda Valeria; Marzola Giuliano; Guerrini Remo; De Risi Carmela; Regoli Domenico; Calo' Girolamo
[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
The Journal of pharmacology and experimental therapeutics 2002;300(1):57-63.
2001: Di Giannuario A; Rizzi A; Pieretti S; Guerrini R; Bertorelli R; Salvadori S; Regoli D; Calo G
Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice.
Neuroscience letters 2001;316(1):25-8.
2001: Lazzeri M; Calò G; Spinelli M; Guerrini R; Beneforti P; Sandri S; Zanollo A; Regoli D; Turini D
Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study.
The Journal of urology 2001;166(6):2237-40.
2001: Guerrini R; Caló G; Bigoni R; Rizzi D; Rizzi A; Zucchini M; Varani K; Hashiba E; Lambert D G; Toth G; Borea P A; Salvadori S; Regoli D
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.
Journal of medicinal chemistry 2001;44(23):3956-64.
2001: Rizzi A; Marzola G; Bigoni R; Guerrini R; Salvadori S; Mogil J S; Regoli D; Calò G
Endogenous nociceptin signaling and stress-induced analgesia.
Neuroreport 2001;12(14):3009-13.
2001: Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(5):551-5.
2001: Guerrini R; Calo' G; Bigoni R; Rizzi D; Regoli D; Salvadori S
Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.
The journal of peptide research : official journal of the American Peptide Society 2001;57(3):215-22.
2001: Rizzi A; Bigoni R; Marzola G; Guerrini R; Salvadori S; Regoli D; Calo' G
Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(2):161-5.
2000: Bigoni R; Rizzi A; Rizzi D; Becker J A; Kieffer B L; Simonin F; Regoli D; Calo G
In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
Life sciences 2000;68(2):233-9.
2000: Quartara L; Ricci R; Meini S; Patacchini R; Giolitti A; Amadesi S; Rizzi C; Rizzi A; Varani K; Borea P A; Maggi C A; Regoli D
Ala scan analogues of HOE 140. Synthesis and biological activities.
European journal of medicinal chemistry 2000;35(11):1001-10.
2000: Rizzi A; Bigoni R; Marzola G; Guerrini R; Salvadori S; Regoli D; Calo G
The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia.
Neuroreport 2000;11(11):2369-72.
2000: Calo' G; Bigoni R; Rizzi A; Guerrini R; Salvadori S; Regoli D
Nociceptin/orphanin FQ receptor ligands.
Peptides 2000;21(7):935-47.
2000: Guerrini R; Calo' G; Rizzi A; Bigoni R; Rizzi D; Regoli D; Salvadori S
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A.
Peptides 2000;21(7):923-33.
2000: Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert D G; Borea P A; Tomatis R; Salvadori S; Regoli D
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Journal of medicinal chemistry 2000;43(15):2805-13.
2000: Regoli D
Toward a new anti-inflammatory and analgesic agent.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(14):7676-7.
2000: Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert D G; Regoli D
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(5):565-8.
2000: Calo' G; Guerrini R; Rizzi A; Salvadori S; Regoli D
Pharmacology of nociceptin and its receptor: a novel therapeutic target.
British journal of pharmacology 2000;129(7):1261-83.
2000: Calo' G; Guerrini R; Bigoni R; Rizzi A; Marzola G; Okawa H; Bianchi C; Lambert D G; Salvadori S; Regoli D
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
British journal of pharmacology 2000;129(6):1183-93.
1999: Rizzi C; Rizzi A; Calò G; Jorizzo G; Agnello G; Mollica G; Inamura N; Regoli D
Characterization of FR 172357, a new non-peptide bradykinin B(2) receptor antagonist, in human, pig and rabbit preparations.
European journal of pharmacology 1999;386(1):25-31.
1999: Rizzi A; Bigoni R; Caló G; Guerrini R; Salvadori S; Regoli D
[Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
European journal of pharmacology 1999;385(2-3):R3-5.
1999: Salvadori S; Guerrini R; Calo G; Regoli D
Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist.
Farmaco (Società chimica italiana : 1989) 1999;54(11-12):810-25.
1999: Rizzi A; Rizzi C; Amadesi S; Calo' G; Varani K; Inamura N; Regoli D
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(4):361-7.
1999: Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea P A; Regoli D
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(3):270-7.
1999: Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi C A
MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
The Journal of pharmacology and experimental therapeutics 1999;289(3):1250-6.
1999: Bigoni R; Giuliani S; Calo' G; Rizzi A; Guerrini R; Salvadori S; Regoli D; Maggi C A
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(3):160-7.
1999: Madeddu P; Salis M B; Milia A F; Emanueli C; Guerrini R; Regoli D; Calò G
Cardiovascular effects of nociceptin in unanesthetized mice.
Hypertension 1999;33(3):914-9.
1999: Bregola G; Varani K; Gessi S; Beani L; Bianchi C; Borea P A; Regoli D; Simonato M
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy.
Neuroscience 1999;92(3):1043-9.
1999: Rizzi A; Calò G; Trevisani M; Tognetto M; Fabbri L; Mapp C; Guerrini R; Salvadori S; Regoli D; Geppetti P
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus.
Life sciences 1999;64(13):PL157-63.
1998: Varani K; Calo G; Rizzi A; Merighi S; Toth G; Guerrini R; Salvadori S; Borea P A; Regoli D
Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships.
British journal of pharmacology 1998;125(7):1485-90.
1998: Rizzi A; Quaglio D; Vasquez G; Mascoli F; Amadesi S; Calò G; Regoli D; Zamboni P
Effects of vasoactive agents in healthy and diseased human saphenous veins.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 1998;28(5):855-61.
1998: Calò G; Rizzi A; Marzola G; Guerrini R; Salvadori S; Beani L; Regoli D; Bianchi C
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.
British journal of pharmacology 1998;125(2):373-8.
1998: Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
Journal of medicinal chemistry 1998;41(18):3360-6.
1998: Emanueli C; Grady E F; Madeddu P; Figini M; Bunnett N W; Parisi D; Regoli D; Geppetti P
Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.
Hypertension 1998;31(6):1299-304.
1998: Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
A new selective antagonist of the nociceptin receptor.
British journal of pharmacology 1998;123(2):163-5.
1997: Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea P A; Regoli D
Human vascular kinin receptors of the B2 type characterized by radioligand binding.
British journal of pharmacology 1997;122(7):1450-4.
1997: Rizzi A; Calò G; Amadesi S; Regoli D
Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(5):662-70.
1997: Cellier E; Barbot L; Regoli D; Couture R
Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
British journal of pharmacology 1997;122(4):643-54.
1997: Regoli D; Rizzi A; Calò G
Pharmacology of the kallikrein-kinin system.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;35(6):513-5.
1997: Calò G; Rizzi A; Bodin M; Neugebauer W; Salvadori S; Guerrini R; Bianchi C; Regoli D
Pharmacological characterization of nociceptin receptor: an in vitro study.
Canadian journal of physiology and pharmacology 1997;75(6):713-8.
1997: Rizzi A; Gobeil F; Bogoni G; Calò G; Campobasso C; Inamura N; Regoli D
Antagonistic effects of FR 173657 on human, pig, rabbit, and guinea pig kinin receptors: an in vitro study.
Canadian journal of physiology and pharmacology 1997;75(6):601-8.
1997: Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
British journal of pharmacology 1997;121(4):773-81.
1997: Guerrini R; Calo G; Rizzi A; Bianchi C; Lazarus L H; Salvadori S; Temussi P A; Regoli D
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.
Journal of medicinal chemistry 1997;40(12):1789-93.
1997: Regoli D; Nguyen K; Caló G
Neurokinin receptors. Comparison of data from classical pharmacology, binding, and molecular biology.
Annals of the New York Academy of Sciences 1997;812():144-6.
1997: Rizzi A; Gobeil F; Calò G; Inamura N; Regoli D
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.
Hypertension 1997;29(4):951-6.
1997: Calò G; Rizzi A; Traina L; Regoli D
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Life sciences 1997;60(4-5):PL63-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Domenico Regoli

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Domenico Regoli (preview)

All Publications